Loading...
We zouden het geweldig vinden als je deel wordt van onze community. Word lid van onze Discord om met ons en andere leden in contact te komen!
- Ticker
- ALSPW.PA
- Price
- 0.13
- Stock movement down
- -0.00 (-2.51%)
- Company name
- Spineway
- Exchange
- (PA ,
- Currency
- EUR )
- Sector
- Healthcare >Medical Instruments & Supplies
- Marktkapitalisatie
- 4.69M
- Ent waarde
- -
- Prijs/Verkoop
- -
- Prijs/Boek
- -
- Div opbrengst
- -
- Div groei
- -
- Jaren van groei
- -
- FCF-uitkering
- -
- Trailing P/E
- -
- Toekomstige P/E
- -
- PEG
- -
- EPS-groei
- -
- 1 jaar rendement
- -80.59%
- 3 jaar rendement
- -97.98%
- 5 jaar rendement
- -94.19%
- 10 jaar rendement
- -88.43%
Laatst bijgewerkt: 2025-08-27
DIVIDENDEN
ALSPW.PA keert geen dividend uit
WAARDERING
Waarderingsverhoudingen
Loading...
Gegevens over waarderingsratio's
| Trailing P/E | - |
| Prijs tot OCF | - |
| Prijs tot FCF | - |
| Prijs tot EBITDA | - |
| EV tot EBITDA | - |
Waardering (verkoop/boekwaarde)
Loading...
Waarderingsgegevens (verkoop/boekwaarde)
| Prijs tot verkoop | - |
| Prijs te boeken | - |
| EV naar verkoop | - |
FINANCIËN
AANDELENINFORMATIE
Voorraadgrafiek
Loading...
Koersgegevens
| Open | 0.14 |
| Dagelijks hoog | 0.14 |
| Dagelijks laag | 0.13 |
| Dagelijks volume | 249K |
| Hoogtepunt aller tijden | 844800000.00 |
| 1y analistenraming | 0.36 |
| Beta | 0.80 |
| WPA (TTM) | - |
| Dividend per aandeel | - |
| Ex-div datum | - |
| Volgende inkomsten datum | - |
Negatief potentieel
Loading...
Nadeel potentiële gegevens
| ALSPW.PA | S&P500 | |
| Huidige prijsdaling vanaf het hoogste punt ooit | -100.00% | -3.04% |
| Hoogste prijsdaling | -100.00% | -56.47% |
| Datum van hoogste daling | 20 Jun 2025 | 9 Mar 2009 |
| Gemiddelde daling vanaf de top | -77.27% | -11.04% |
| Gemiddelde tijd tot nieuwe high | 526 days | 12 days |
| Max tijd tot nieuwe hoogte | 2929 days | 1805 days |
BEDRIJFSGEGEVENS
Marktkapitalisatie
4.69M
Marktkapitalisatie categorie
Small-cap
Beschrijving
Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The company was incorporated in 2005 and is headquartered in Ecully, France.
Werknemers
43
Website
Investeerdersrelaties
-
SEC-dossiers
CEO
Land
France
Stad
Type aandeel
-
CCC-status
-
Dividendfrequentie
-
EVENEMENTEN EN PRESENTATIES
EvenementenPresentaties
Loading...
HET BEDRIJF BEGRIJPEN
Loading...
BEDRIJFSNIEUWS
Alle nieuwsPersberichten
Press release Ecully, July 30, 2025 – 7 p.m. SPINEWAY H1 2025 results Continued improvement in results and financial positionFull-year 2025 growth target confirmed In thousands of eurosConsolidated fi...
30 juli 2025
Press release Ecully, July 3, 2025 – 6:30 p.m. SPINEWAY GMED approval for new production line dedicated to ESP prostheses First production of LP-ESP intervertebral disc prostheses Spineway, a speciali...
3 juli 2025
Press release Ecully, June 6, 2025 – 6.00 p.m. SPINEWAY Minutes of the General Meeting of June 4, 2025 The Combined General Meeting (Ordinary and Extraordinary) of Spineway shareholders was held on fi...
6 juni 2025
Press release Ecully, May 19, 2025 – 6.30 p.m. SPINEWAY Combined General Meeting of June 4, 2025Availability of preparatory documents Spineway informs its shareholders that they are invited to attend ...
19 mei 2025
Press release Ecully, April 16, 2025 – 7.00 p.m. SPINEWAY First-quarter 2025 revenue of €2.8 million In thousands of euros20252024Change as a %Q1 revenue2,8283,070-8% Unaudited consolidated data Spine...
16 april 2025
Press release Ecully, March 24, 2025 – 6 p.m. SPINEWAY Consolidated 2024 annual results Annual revenue of €12 million (+14%)Operating income close to breakevenReduction in net loss In thousands of eur...
24 maart 2025
Press release Ecully, February 27, 2025 – 6.30 p.m. Spineway marks its return to Arab Health 2025 with new distribution agreements Spineway, a specialist in innovative implants for the treatment of se...
27 februari 2025
Press release Ecully, January 22, 2025 – 6.30 p.m. SPINEWAY 2024 revenue of €12 million 14% growth compared with 2023 In thousands of euros20242023Change as a %H1 revenue6,5355,431+20%H2 revenue5,4155...
22 januari 2025
Press release Ecully, December 18, 2024 – 6 p.m. Spineway wins new approvals in Vietnam and registers initial orders The Spineway Group, a specialist in innovative implants for the treatment of severe...
18 december 2024
Press release Ecully, December 6, 2024 – 6 p.m. Spineway provides an update on its activities during a webinarArrival of a new CFO The Spineway Group, a specialist in innovative implants for the treat...
6 december 2024
Volgende pagina